Literature DB >> 9846972

T cell apoptosis in human heart allografts: association with lack of co-stimulation?

E Van Hoffen1, D F Van Wichen, J C Leemans, R A Broekhuizen, A H Bruggink, M De Boer, N De Jonge, H Kirkels, P J Slootweg, F H Gmelig-Meyling, R A De Weger.   

Abstract

It is unclear whether the intracardial immune reactivity after heart transplantation influences the peripheral immunological status (activation or nonresponsiveness) of the patient. Co-stimulation and activation-induced cell death (AICD) or apoptosis play an important role in determining the balance between lymphocyte reactivity and nonreactivity. Therefore, we studied the expression of co-stimulatory molecules and the process of apoptosis in biopsies of human heart allografts, using immunohistochemistry. Although a normal expression of co-stimulatory molecules on antigen-presenting cells was observed, the expression of their counter-structures on T cells was absent. This may be due to chronic T cell activation, which can lead to the induction of apoptosis via the Fas/Fas ligand pathway. In the infiltrates, a considerable percentage of the lymphocytes, but not the macrophages, were apoptotic. Apoptosis was confirmed by DNA fragmentation analysis. Increased numbers of Bax-expressing versus decreased numbers of Bcl2-expressing lymphocytes in comparison with normal lymphoid tissue confirmed a imbalance in favor of apoptosis. Apoptosis was biased towards CD4+ T cells (65.7% versus 26.6% in CD8+ T cells). Fas was expressed on most of the infiltrating cells. Fas ligand expression was also observed, not only on most of the T cells but also on all macrophages. Because macrophages were often detected in close contact with T cells, they may play a role in T cell regulation via the Fas/Fas ligand pathway. This study indicates that, during rejection, not only is tissue damage induced by infiltrating T cells, but also the infiltrating lymphocytes themselves are actively down-regulated (eg, AICD) by one another and by macrophages in the infiltrate. This regulatory process may affect the immunological status of the patient after heart transplantation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846972      PMCID: PMC1866320          DOI: 10.1016/S0002-9440(10)65696-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

Authors:  M E Billingham; N R Cary; M E Hammond; J Kemnitz; C Marboe; H A McCallister; D C Snovar; G L Winters; A Zerbe
Journal:  J Heart Transplant       Date:  1990 Nov-Dec

2.  CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.

Authors:  P S Linsley; J Bradshaw; M Urnes; L Grosmaire; J A Ledbetter
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

3.  Effect of bcl-2 on Fas antigen-mediated cell death.

Authors:  N Itoh; Y Tsujimoto; S Nagata
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

Review 4.  Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?

Authors:  M H Schreier; G Baumann; G Zenke
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  Reduction of donor-specific cytotoxic T lymphocyte precursors in peripheral blood of allografted heart recipients.

Authors:  H Hu; M Robertus; N de Jonge; F H Gmelig-Meyling; A van der Meulen; H J Schuurman; H Doornewaard; H C van Prooijen; R A de Weger
Journal:  Transplantation       Date:  1994-12-15       Impact factor: 4.939

6.  Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA.

Authors:  M D Jacobson; J F Burne; M P King; T Miyashita; J C Reed; M C Raff
Journal:  Nature       Date:  1993-01-28       Impact factor: 49.962

7.  Chagasic patients lack CD28 expression on many of their circulating T lymphocytes.

Authors:  W O Dutra; O A Martins-Filho; J R Cançado; J C Pinto-Dias; Z Brener; G Gazzinelli; J F Carvalho; D G Colley
Journal:  Scand J Immunol       Date:  1996-01       Impact factor: 3.487

8.  Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.

Authors:  K S Hathcock; G Laszlo; C Pucillo; P Linsley; R J Hodes
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

9.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

10.  Fas ligand mediates activation-induced cell death in human T lymphocytes.

Authors:  M R Alderson; T W Tough; T Davis-Smith; S Braddy; B Falk; K A Schooley; R G Goodwin; C A Smith; F Ramsdell; D H Lynch
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more
  4 in total

1.  Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients.

Authors:  L A Chau; S Rohekar; J-J Wang; D Lian; S Chakrabarti; L Zhang; R Zhong; J Madrenas
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure.

Authors:  B E Burrell; J S Bromberg
Journal:  Am J Transplant       Date:  2011-12-17       Impact factor: 8.086

3.  Expression of CD80 on Kupffer cells is enhanced in cadaveric liver transplants.

Authors:  J Kwekkeboom; M A Kuijpers; B Bruyneel; S Mancham; E De Baar-Heesakkers; J N M Ijzermans; G J Bouma; P E Zondervan; H W Tilanus; H J Metselaar
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

4.  Immune responses to self-antigens (autoimmunity) in allograft rejection.

Authors:  Sabarinathan Ramachandran; Vijay Subramanian; Thalachallour Mohanakumar
Journal:  Clin Transpl       Date:  2012
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.